ASSOCIATION OF FASTING PLASMA GLUCOSE LEVEL ON ADMISSION OF COVID-19 PATIENTS- AN OBSERVATIONAL STUDY

Abstract

Listen

Translate article

Introduction: The coronavirus disease 2019 (COVID-19) pandemic, which was caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, is a novel and serious global health threat and has dramatically spread worldwide 1. COVID-19 is transmitted primarily through respiratory droplet and direct contact. At the time of this article's drafting, 188,616,093 conrmed cases and 4,065,804 deaths have been reported worldwide with new conrmed cases and deaths occurring per day Materials And Methods: All COVID-19 patients consecutively admitted to the hospital between June 1, 2020, and July 31, 2021, were collected. The diagnosis and clinical classication (mild, moderate, severe, and critical) of COVID-19 patients were carried out by two independent doctors based on the Guideline of Novel Coronavirus Pneumonia (8 th revised Edition) issued by the Chinese National Health Commission. Result: Among 202 diagnosed COVID-19 patients from June 2020 to July 2021, some patients were excluded for age < 18 years (n = 5), pregnant women (n = 3), combined with malignant tumor (n = 1), no available or incomplete laboratory data (n = 120), no FPG data available at admission (n = 44), and patients diagnosed before June or discharged in August (n = 29) were excluded. Finally, 99 cases were included in the study Conclusion: Higher FPG was an independent predictor of prolonged duration of SARS-CoV-2 RNA shedding/clearance in the present study. Our ndings indicate that screening FPG level is an effective and simple method to evaluate the prognosis of patients with COVID-19, and intervention should be taken in time when patients with FPG ≥ 6:1 mmol/l regardless of a history of diabetes.